InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the complete record of transactions filed by Schemel Donald Robert, Director. Insider active across 1 company, notably Panbela Therapeutics, Inc.. Cumulatively, 2 filings have been published. Split: 1 buy · 0 sell. History available since 25 May 2021. The latest transaction was disclosed on 25 May 2021 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Schemel Donald Robert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
200,000 sharesCommon StockSEC:0001437749-22-023773:0
Canonical exit: 2 Jan 2023 (T+90)
4,316 shares0Common StockSEC:0001437749-21-013594:0
2 of 2 declarations
About Schemel Donald Robert
Donald Robert Schemel is a Board Member at Panbela Therapeutics, Inc. He brings significant expertise in the biotechnology sector, contributing to the strategy and governance of the company. His role includes evaluating operational performance and guiding growth initiatives. He is committed to supporting innovation and improving services.
